A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-160…
Overview of attention for article published in Journal of Thoracic Oncology, January 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Mentioned by
- 1 Facebook page
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 97 Mendeley